Newest first. 5.2k questions across 107 tags.
Details up front: TSH · retatrutide. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how confident…
What I have: minus 80 °C · dulaglutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence exists…
Conditions: magnesium · twelve weeks · orforglipron. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident…
Conditions: 96.4% · date of analysis. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
The particulars: tirzepatide · STEP 5. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The particulars: SURMOUNT-3 · semaglutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The specifics, since they change the answer: VendorInvestigate · 97.9%. An unexpected observation, and I would like a differential rather than reassurance. The…
Stated plainly: purity figure · WWB. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including the…
The clinician who ordered the panel was not concerned; I would still like to understand it. This is not behaving the way I expected and I want to understand the…
Setup, so nobody has to ask: aggregation · cagrilintide · 25 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me…
Stated plainly: headache · mazdutide · STEP 5. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Stated plainly: BCH · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched the…
Setup, so nobody has to ask: 98.8% · a GLP-1 receptor agonist. I have worked this out and I would like someone to find the error, because I suspect there is one. My…
Numbers first: cagrilintide · 25 °C · twenty-eight days. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell…
Details up front: mazdutide · 2.5 mg/mL. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
Numbers first: a GLP-1 receptor agonist · 1 mg/mL · eight weeks. I would rather be corrected now than propagate something wrong. I am specifically not interested in a…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I can do the algebra. I am not confident about the conversion factors. If…
What I have: SWB · ERP · Australia. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
Details up front: ESSENCE · constipation · 15 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear…
Numbers first: STEP 8 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
The case in front of me: survodutide · a C4 column · tirzepatide. These are treated as interchangeable and I do not think they are. If both are acceptable I would…
The case in front of me: TRIUMPH-3 · fatigue · 5 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if…
The case in front of me: Shanghai · Japan. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Conditions: 12 units · 5 mg/mL. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one mistake here that…